帕金森病的干细胞移植治疗
Stem cell transplantation therapy in Parkinson's disease.
作者信息
Fu Mu-Hui, Li Chia-Ling, Lin Hsiu-Lien, Chen Pei-Chun, Calkins Marcus J, Chang Yu-Fan, Cheng Pei-Hsun, Yang Shang-Hsun
机构信息
Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, 70101 Taiwan.
Department of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, 83301 Taiwan.
出版信息
Springerplus. 2015 Oct 13;4:597. doi: 10.1186/s40064-015-1400-1. eCollection 2015.
Abstract
Ineffective therapeutic treatments and inadequate repair ability in the central nervous system are disturbing problems for several neurological diseases. Fortunately, the development of clinically applicable populations of stem cells has provided an avenue to overcome the failure of endogenous repair systems and substitute new cells into the damaged brain. However, there are still several existing obstacles to translating into clinical application. Here we review the stem-cell based therapies for Parkinson's disease and discuss the potential advantages and drawbacks. We hope this review may provide suggestions for viable strategies to overcome the current technical and biological issues associated with the application of stem cells in Parkinson's disease.
摘要
中枢神经系统中无效的治疗方法和不足的修复能力是几种神经疾病令人困扰的问题。幸运的是，临床适用的干细胞群体的发展为克服内源性修复系统的失败以及将新细胞替代到受损大脑中提供了一条途径。然而，转化为临床应用仍存在一些现有障碍。在此，我们综述基于干细胞治疗帕金森病的方法，并讨论其潜在的优缺点。我们希望这篇综述可为克服目前与干细胞在帕金森病应用相关的技术和生物学问题的可行策略提供建议。
相似文献
1
Stem cell transplantation therapy in Parkinson's disease.帕金森病的干细胞移植治疗
Springerplus. 2015 Oct 13;4:597. doi: 10.1186/s40064-015-1400-1. eCollection 2015.
2
Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives.干细胞移植疗法与神经系统疾病：现状与未来展望
Biology (Basel). 2022 Jan 17;11(1):147. doi: 10.3390/biology11010147.
3
Therapeutic potential of stem cells for treatment of neurodegenerative diseases.干细胞治疗神经退行性疾病的治疗潜力。
Biotechnol Lett. 2020 Jul;42(7):1073-1101. doi: 10.1007/s10529-020-02886-1. Epub 2020 Apr 27.
4
Stem cell-based cell therapy in neurological diseases: a review.基于干细胞的细胞疗法在神经疾病中的应用：综述
J Neurosci Res. 2009 Aug 1;87(10):2183-200. doi: 10.1002/jnr.22054.
5
Stem cell therapy for Parkinson's disease: safety and modeling.帕金森病的干细胞治疗：安全性与模型构建
Neural Regen Res. 2020 Jan;15(1):36-40. doi: 10.4103/1673-5374.264446.
6
The future of cell-based transplantation therapies for neurodegenerative disorders.用于神经退行性疾病的基于细胞的移植疗法的未来。
J Hematother Stem Cell Res. 2003 Dec;12(6):635-42. doi: 10.1089/15258160360732669.
7
Progress and prospects: stem cells and neurological diseases.进展与展望：干细胞与神经退行性疾病
Gene Ther. 2011 Jan;18(1):1-6. doi: 10.1038/gt.2010.130. Epub 2010 Sep 30.
8
[Current cell therapy strategies for repairing the central nervous system].[当前用于修复中枢神经系统的细胞治疗策略]
Rev Neurol (Paris). 2007 Sep;163 Spec No 1:3S23-30.
9
The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.干细胞在帕金森病和亨廷顿病再生医学中的应用。
Curr Med Chem. 2012;19(35):6018-35.
10
Organotypic cultures as tools for optimizing central nervous system cell therapies.器官型培养物作为优化中枢神经系统细胞疗法的工具。
Exp Neurol. 2013 Oct;248:429-40. doi: 10.1016/j.expneurol.2013.07.012. Epub 2013 Jul 27.
引用本文的文献
1
Neural stem cells derived from α-synuclein-knockdown iPS cells alleviate Parkinson's disease.源自α-突触核蛋白敲低诱导多能干细胞的神经干细胞可缓解帕金森病。
Cell Death Discov. 2024 Sep 17;10(1):407. doi: 10.1038/s41420-024-02176-z.
2
Long-range axonal projections of transplanted mouse embryonic stem cell-derived hypothalamic neurons into adult mouse brain.移植的小鼠胚胎干细胞源性下丘脑神经元在成年小鼠大脑中的长程轴突投射。
PLoS One. 2022 Nov 10;17(11):e0276694. doi: 10.1371/journal.pone.0276694. eCollection 2022.
3
miR-196a enhances polymerization of neuronal microfilaments through suppressing IMP3 and upregulating IGF2 in Huntington's disease.在亨廷顿舞蹈病中，miR-196a通过抑制IMP3并上调IGF2来增强神经元微丝的聚合。
Mol Ther Nucleic Acids. 2022 Oct 10;30:286-299. doi: 10.1016/j.omtn.2022.10.002. eCollection 2022 Dec 13.
4
A comparative study of the capability of MSCs isolated from different human tissue sources to differentiate into neuronal stem cells and dopaminergic-like cells.不同组织来源的间充质干细胞向神经干细胞和多巴胺能样细胞分化能力的比较研究。
PeerJ. 2022 Mar 17;10:e13003. doi: 10.7717/peerj.13003. eCollection 2022.
5
Multifactoriality of Parkinson's Disease as Explored Through Human Neural Stem Cells and Their Transplantation in Middle-Aged Parkinsonian Mice.通过人类神经干细胞及其在中年帕金森病小鼠中的移植探索帕金森病的多因素性
Front Pharmacol. 2022 Jan 19;12:773925. doi: 10.3389/fphar.2021.773925. eCollection 2021.
6
Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives.干细胞移植疗法与神经系统疾病：现状与未来展望
Biology (Basel). 2022 Jan 17;11(1):147. doi: 10.3390/biology11010147.
7
The Role of Autophagy in Anti-Cancer and Health Promoting Effects of Cordycepin.虫草素在抗癌和促进健康方面的作用：自噬的角色。
Molecules. 2021 Aug 16;26(16):4954. doi: 10.3390/molecules26164954.
8
The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease.微小 RNA 在亨廷顿病发病机制和治疗中的调控作用。
J Biomed Sci. 2021 Aug 19;28(1):59. doi: 10.1186/s12929-021-00755-1.
9
Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview.再生干细胞疗法治疗神经退行性疾病：概述。
Int J Mol Sci. 2021 Feb 22;22(4):2153. doi: 10.3390/ijms22042153.
10
Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.多巴胺在哪里，免疫细胞如何感知它？：多巴胺介导的免疫细胞在健康和疾病中的功能。
J Neuroimmune Pharmacol. 2020 Mar;15(1):114-164. doi: 10.1007/s11481-019-09851-4. Epub 2019 May 11.
本文引用的文献
1
Complete rat spinal cord transection as a faithful model of spinal cord injury for translational cell transplantation.完全性大鼠脊髓横断作为用于转化细胞移植的脊髓损伤可靠模型。
Sci Rep. 2015 Apr 10;5:9640. doi: 10.1038/srep09640.
2
Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury.干细胞源性星形胶质细胞移植治疗肌萎缩侧索硬化症和脊髓损伤。
World J Stem Cells. 2015 Mar 26;7(2):380-98. doi: 10.4252/wjsc.v7.i2.380.
3
Stemness enhancement of human neural stem cells following bone marrow MSC coculture.骨髓间充质干细胞共培养后人类神经干细胞干性增强
Cell Transplant. 2015;24(4):645-59. doi: 10.3727/096368915X687561. Epub 2015 Feb 24.
4
MiR-124 promotes bone marrow mesenchymal stem cells differentiation into neurogenic cells for accelerating recovery in the spinal cord injury.微小RNA-124促进骨髓间充质干细胞分化为神经源性细胞以加速脊髓损伤的恢复。
Tissue Cell. 2015 Apr;47(2):140-6. doi: 10.1016/j.tice.2015.01.007. Epub 2015 Feb 2.
5
Enhanced differentiation of neural progenitor cells into neurons of the mesencephalic dopaminergic subtype on topographical patterns.在地形模式上增强神经祖细胞向中脑多巴胺能亚型神经元的分化。
Biomaterials. 2015 Mar;43:32-43. doi: 10.1016/j.biomaterials.2014.11.036. Epub 2014 Dec 23.
6
Transplantation of cerebellar neural stem cells improves motor coordination and neuropathology in Machado-Joseph disease mice.小脑神经干细胞移植改善 Machado-Joseph 病小鼠的运动协调和神经病理学。
Brain. 2015 Feb;138(Pt 2):320-35. doi: 10.1093/brain/awu352. Epub 2014 Dec 19.
7
Pluripotent stem cell-based models of spinal muscular atrophy.基于多能干细胞的脊髓性肌萎缩症模型。
Mol Cell Neurosci. 2015 Jan;64:44-50. doi: 10.1016/j.mcn.2014.12.005. Epub 2014 Dec 12.
8
Lmx1a enhances the effect of iNSCs in a PD model.Lmx1a增强了诱导性神经干细胞（iNSCs）在帕金森病（PD）模型中的作用。
Stem Cell Res. 2015 Jan;14(1):1-9. doi: 10.1016/j.scr.2014.10.004. Epub 2014 Oct 18.
9
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.间充质干细胞：免疫调节和治疗的新兴机制。
World J Stem Cells. 2014 Nov 26;6(5):526-39. doi: 10.4252/wjsc.v6.i5.526.
10
Mesenchymal stem cells for inducing tolerance in organ transplantation.间充质干细胞在器官移植中诱导免疫耐受的研究进展。
Front Cell Dev Biol. 2014 Mar 17;2:8. doi: 10.3389/fcell.2014.00008. eCollection 2014.
Zotero 插件